Westwood Holdings Group Inc Biomarin Pharmaceutical Inc Transaction History

Westwood Holdings Group Inc

$12.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $479,157 - $565,354	-5,832 Reduced 45.79%	6,904 $586,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $5,432 - $6,600	-76 Reduced 0.59%	12,736 $1.06 Million
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $109,488 - $136,625	-1,474 Reduced 10.32%	12,812 $988,000
Q4 2021 Feb 25, 2022	BUY	$71.72 - $91.47 $423,578 - $540,221	5,906 Added 70.48%	14,286 $1.26 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $50,320 - $57,521	-673 Reduced 7.43%	8,380 $648,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $297,358 - $333,903	-3,938 Reduced 30.31%	9,053 $755,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $119,866 - $145,466	-1,604 Reduced 10.99%	12,991 $981,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $47,632 - $59,171	-656 Reduced 4.3%	14,595 $1.28 Million
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $65,186 - $118,844	-907 Reduced 5.61%	15,251 $1.16 Million
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $154,565 - $241,359	1,943 Added 13.67%	16,158 $1.99 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $132,605 - $179,947	-1,858 Reduced 11.56%	14,215 $1.2 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $12,854 - $17,274	-200 Reduced 1.23%	16,073 $1.36 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $38,013 - $48,002	-564 Reduced 3.35%	16,273 $1.1 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $162,869 - $190,335	-2,027 Reduced 10.75%	16,837 $1.44 Million
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $15,913 - $18,639	-189 Reduced 0.99%	18,864 $1.68 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $35,021 - $46,352	-437 Reduced 2.24%	19,053 $1.62 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $380,657 - $428,483	-4,053 Reduced 17.22%	19,490 $1.89 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $480,611 - $626,166	6,323 Added 36.72%	23,543 $2.22 Million
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $1.34 Million - $1.6 Million	17,220 New	17,220 $1.4 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Account